Ontology highlight
ABSTRACT: Objective
Few studies have evaluated the benefits of colorectal cancer (CRC) screening integrating both non-genetic and genetic risk factors. Here, we aimed to integrate an existing non-genetic risk model (QCancer-10) and a 139-variant polygenic risk score to evaluate the effectiveness of screening on CRC incidence and mortality.Methods
We applied the integrated model to calculate 10-year CRC risk for 430,908 participants in the UK Biobank, and divided the participants into low-, intermediate-, and high-risk groups. We calculated the screening-associated hazard ratios (HRs) and absolute risk reductions (ARRs) for CRC incidence and mortality according to risk stratification.Results
During a median follow-up of 11.03 years and 12.60 years, we observed 5,158 CRC cases
SUBMITTER: Zhang Y
PROVIDER: S-EPMC11359493 | biostudies-literature | 2024 Jun
REPOSITORIES: biostudies-literature